GlobalView

Lamb, David S.

Statistics
Title Hits Visitors Downloads
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial 59 43 0
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer 175 158 0
A methodology for the analysis of PSA response signatures 66 59 0
PSA response signatures: a powerful new prognostic indicator after radiation for prostate cancer? 145 134 0
Measuring time to biochemical failure in the Trog 96.01 trial: when should the clock start ticking? 176 168 0
Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer 57 50 0
A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR 47 42 0
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial 63 52 0
Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial 86 61 0
Risk stratification after biochemical failure following curative treatment of locally advanced prostate cancer: data from the TROG 96.01 trial 47 37 0
Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer 101 72 0
Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival? 171 153 0
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial 165 145 0
A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial 214 199 0
Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials 18 17 0
A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial 77 61 0
Survival benefit confirmed for prostate cancers diagnosed by PSA testing (letter) 106 87 0
The effect, moderators, and mediators of resistance and aerobic exercise on health-related quality of life in older long-term survivors of prostate cancer 3 3 0
Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial 5 5 0
Repository Search URL

Lamb, David S.

Formatted Bibliography URL

Lamb, David S.

Bibliography Markup

To include a live feed of this author's bibliography on a static Web page (e.g., a personal home page), add the following HTML code to the body of your HTML.